Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle
Biophytis SA American Depositary Share (0.01 Euro) | FinOracle

Biophytis SA American Depositary Share (0.01 Euro)

Symbol: (NASDAQ:BPTS)

Biophytis SA is a clinical-stage biotechnology company specialized in developing innovative therapeutics for age-related diseases. Leveraging on its expertise in biology, pharmacology, and bioinformatics, the company focuses on targeting the dysfunctions of key organs to improve the overall health and quality of life for aging patients.

Latest News

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Home
Trends
Premium
Favorite
Account
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?